Everly Well, Inc.

Sure.

So this is being sold through Everly Well online.

You send in your last mammogram images and they run it through, Clarity runs it through their AI.

Using that, they estimate your five-year odds of developing breast cancer, and they rank you as average, intermediate and high risk for developing breast cancer.

Yeah, it's now commercialized.

You can actually get a company called Everly Well.

You could contact them, and you have to pay for it.

Insurance doesn't cover it yet.

Today, I'm talking with Dr. Liz Kuo, CEO of Vannon Health, and also a Harvard Medical School lecturer and still a practicing physician at Cambridge Health Alliance.

She's led at places like Amwell, Everly Well, and Infinite MD, and she wrote Clinician to Executive.

We dig into what exam room catches that claims miss, building a coach workforce for serious mental illness, the outcomes payers still won't pay for, housing in the Sunday text, and why her favorite proof point is a member

who graduates off the service.

The test has been approved by the Food and Drug Administration.

It's offered through a company called EverlyWell, and it costs $249, not covered by insurance.

And the rich get healthier.

Anyway, as all the women listening to this pod know, doctors already use mammograms to find cancer

Microsoft rebuild co-pilot around autonomous work.

And in health AI, Everly Well launched the first FDA-authorized AI for five-year breast cancer risk from a mammogram, while the Mayo Clinic presented a new pancreatic cancer risk model.

Which brings us back to today's top story.

Every one of those agents needs Compute.

And you know, I think what I discovered with these companies like Viome Health, um, Tally Health, which tests your genetic age, um, Tiny Health I mentioned.

Um, there's another company called Everlywell, which is sort of almost like an online store for lots of different tests.

Um, a lot of the information is a little bit hard to interpret or not medically meaningful.

Um, and so it's that, it's that category where it's this sort of regulatory gray area, um, where there is no doctor in the loop in a lot of cases that I think is really interesting.